Pressure Wire Assessment of Hemodynamic Alterations after Chemoembolization of Hepatocellular Carcinoma

被引:5
作者
Borowski, Allison M. [1 ]
Frangos, Andrea [1 ]
McCann, Jeffrey W. [1 ]
Brown, Daniel B. [2 ]
机构
[1] Thomas Jefferson Univ, Dept Radiol, Div Intervent Radiol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
关键词
Hepatocellular carcinoma; chemoembolization; endpoint determination; arterial pressure measurement; INTRAARTERIAL PERFUSION MRI; RANDOMIZED CONTROLLED TRIAL; ARTERIAL EMBOLIZATION; END-POINTS; DELIVERY; STENT;
D O I
10.1016/j.acra.2013.02.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives: The end point of chemoembolization for hepatocellular carcinoma is qualitative. We intended to determine the feasibility of measuring, intra-arterial pressure changes after chemoembolization and hypothesized that pressures would increase in the distal hepatic artery after the procedure. Materials and Methods: Before and after chemoembolization, systemic (S) systolic and mean pressures were measured along with celiac (C), lobar (L), and distal (D) hepatic artery pressures with a pressure wire. Corrected pressures were defined as a ratio with S as the denominator to account for intraprocedural S changes. Changes in the systolic and mean corrected pressures at each location (C/S, L/S, and D/S) were evaluated using paired t tests. Pressure changes in patients with and without tumor response using the Modified Response Evaluation Criteria in Solid Tumors were also compared. Results: Sixteen tumors were treated in 15 patients. One patient had bilobar tumors with separate supplying arteries. The only significant pressure change was systolic D/S (P = .02), while mean D/S approached significance (P = .08). C/S and US did not change significantly after chemoembolization. Eleven of 16 patients had a complete response, whereas the other five had a partial response after chemoembolization. When comparing complete to partial responders, no changes in systolic or mean C/S, US, or D/S reached statistical significance (all P > .05). Conclusions: Measuring change in hepatic artery pressures is feasible. Distal intra-arterial corrected pressures increase significantly after chemoembolization. Further study to determine the ability to predict tumor necrosis at follow-up imaging is warranted.
引用
收藏
页码:1037 / 1040
页数:4
相关论文
共 16 条
[1]   Targeted drug delivery under MRI guidance [J].
Arepally, Aravind .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 27 (02) :292-298
[2]   Society of Interventional Radiology Position Statement on Chemoembolization of Hepatic Malignancies (Reprinted from J Vasc Interv Radiol vol 17, pg 217-223, 2006) [J].
Brown, Daniel B. ;
Geschwind, Jean-Francois H. ;
Soulen, Michael C. ;
Millward, Steven F. ;
Sacks, David .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 20 (07) :S317-S323
[3]   Locoregional Chemoembolic Delivery: Prediction With Transcatheter Intraarterial Perfusion MRI [J].
Gaba, Ron C. ;
Jin, Brian ;
Wang, Dingxin ;
Lewandowski, Robert J. ;
Ragin, Ann B. ;
Larson, Andrew C. ;
Salem, Riad ;
Omary, Reed A. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (05) :1196-1202
[4]   A multicentre evaluation of the Medtronic AVE Flexible Iliac Bridge Stent in the iliac arteries (the first study) [J].
Gaines, PA ;
Schulte, KL ;
Müller-Hülsbeck, S ;
Seelen, J ;
Maleux, G ;
van Overhagen, H ;
Cleveland, TJ .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2005, 29 (02) :124-130
[5]   Quantitative 4D Transcatheter Intraarterial Perfusion MRI for Standardizing Angiographic Chemoembolization Endpoints [J].
Jin, Brian ;
Wang, Dingxin ;
Lewandowski, Robert J. ;
Ryu, Robert K. ;
Sato, Kent T. ;
Larson, Andrew C. ;
Salem, Riad ;
Omary, Reed A. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (05) :1237-1243
[6]   Chemoembolization Endpoints: Effect on Survival Among Patients With Hepatocellular Carcinoma [J].
Jin, Brian ;
Wang, Dingxin ;
Lewandowski, Robert J. ;
Riaz, Ahsun ;
Ryu, Robert K. ;
Sato, Kent T. ;
Larson, Andrew C. ;
Salem, Riad ;
Omary, Reed A. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 196 (04) :919-928
[7]   Dutch iliac stent trial: Long-term results in patients randomized for primary or selective stent placement [J].
Klein, WM ;
van der Graaf, Y ;
Seegers, J ;
Spithoven, JH ;
Buskens, E ;
van Baal, JG ;
Buth, J ;
Moll, FL ;
Overtoom, TTC ;
van Sambeek, MRHM ;
Mali, WPTM .
RADIOLOGY, 2006, 238 (02) :734-744
[8]   The burden of illness associated with hepatocellular carcinoma in the United States [J].
Lang, Kathleen ;
Danchenko, Natalya ;
Gondek, Kathleen ;
Shah, Sonalee ;
Thompson, David .
JOURNAL OF HEPATOLOGY, 2009, 50 (01) :89-99
[9]   Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma [J].
Lencioni, Riccardo ;
Llovet, Josep M. .
SEMINARS IN LIVER DISEASE, 2010, 30 (01) :52-60
[10]   Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial [J].
Llovet, JM ;
Real, MI ;
Montaña, X ;
Planas, R ;
Coll, S ;
Aponte, J ;
Ayuso, C ;
Sala, M ;
Muchart, J ;
Solà, R ;
Rodés, J ;
Bruix, J .
LANCET, 2002, 359 (9319) :1734-1739